Cargando…
MicroRNA-22 contributes to dexamethasone-induced osteoblast differentiation inhibition and dysfunction through targeting caveolin-3 expression in osteoblastic cells
Osteoporosis is a common complication of long-term use of glucocorticoids (GCs) characterized by the loss of bone mass and damage of the microarchitecture as well as osteoblast dysfunction. Previous studies have demonstrated that microRNA-22 (miR-22) is the negative modulator of osteogenesis that ma...
Autores principales: | Li, Peng, Mao, Weiwei, Zhang, Shuai, Zhang, Liang, Chen, Zhirong, Lu, Zhidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903452/ https://www.ncbi.nlm.nih.gov/pubmed/33732309 http://dx.doi.org/10.3892/etm.2021.9767 |
Ejemplares similares
-
MicroRNA-200a activates Nrf2 signaling to protect osteoblasts from dexamethasone
por: Zhao, Sai, et al.
Publicado: (2017) -
MicroRNA-21 facilitates osteoblast activity
por: Oka, Shunichi, et al.
Publicado: (2020) -
microRNA-19a protects osteoblasts from dexamethasone via targeting TSC1
por: Liu, Gang, et al.
Publicado: (2017) -
MicroRNA‐142 regulates osteoblast differentiation and apoptosis of mouse pre‐osteoblast cells by targeting bone morphogenetic protein 2
por: Luo, Bing, et al.
Publicado: (2020) -
Sodium hydrosulfide alleviates dexamethasone-induced cell senescence and dysfunction through targeting the miR-22/sirt1 pathway in osteoblastic MC3T3-E1 cells
por: Li, Peng, et al.
Publicado: (2021)